University of California San Francisco
TEDx San Francisco and UCSF Global Health Sciences are uniting forces for the first time ever to showcase "7 Billion Well," a global health-focused TEDx event on November 10.
Hospitalized heart failure patients who received the drug, serelaxin, in a phase III clinical trial had fewer disease symptoms and as a group experienced 37 percent fewer deaths over six months, according to results of a new study.
TEDx San Francisco and UCSF Global Health Sciences are uniting forces for the first time ever to showcase "7 Billion Well," a global health-focused TEDx event on November 10.